Madam Speaker, we were clear in the Speech from the Throne, the fall economic statement and budget 2021 that we are committed, now more than ever, to accelerating the implementation of pharmacare. In doing so, we will continue with our measured and considered approach. We must proceed in a way that respects provincial and territorial jurisdictions and leverage their expertise. That is why we are moving forward with willing provinces and territories, without delay, in accelerating steps to achieve this system, including establishing a Canadian drug agency, a national formulary and a national strategy for high-cost drugs for rare diseases.
In the House of Commons on May 27th, 2021. See this statement in context.